Government Revises Financial Disclosure Rules

Researchers welcome a new ruling saying that financial holdings will no longer need to be published in an online database.

Written byEdyta Zielinska
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, KMCCOYAs part of a revision to the Stop Trading on Congressional Knowledge (STOCK) Act enacted last year, researchers will no longer have to disclose their investments—a requirement that some said was an invasion of privacy that would hinder the government’s ability to recruit and retain government scientists. Monday (April 18) President Obama signed a law eliminating that requirement from the bill.

When the bill was first enacted last April, researchers from the National Institutes of Health and NASA joined in a lawsuit to block the law. The STOCK Act was intended to prevent insider trading by members of Congress, but also required 28,000 senior members of the executive branch, which included some members of the NIH staff, to report their assets and nonfederal income as well as the incomes of their spouses and children.

The federal employees have now withdrawn their lawsuit. “I can't tell you how great it feels to have closure,” Joshua Zimmerberg, a researcher at the National Institute of Child Health and Human Development, who helped organize the effort, told ScienceInsider.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies